Drug intelligence / Profile preview

Vizokul

Development stage
Unknown
Lead developer
Akrovis
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Vizokul is an over-the-counter (OTC) ophthalmic solution marketed by Akrovis Pharmaceuticals, a generic and consumer healthcare company based in India. The product is a combination formulation typically containing the decongestants naphazoline hydrochloride and phenylephrine hydrochloride, along with cooling agents such as camphor and menthol. It is indicated for the temporary relief of eye redness, minor irritation, and congestion caused by environmental factors like dust, smoke, or wind. Naphazoline and phenylephrine act as sympathomimetic amines that stimulate alpha-adrenergic receptors, leading to vasoconstriction of the conjunctival blood vessels and a reduction in ocular redness. Menthol and camphor provide a cooling, soothing sensation on the ocular surface.

Brand names
Vizokul
Other names
Vizokul Eye Drops
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Vizokul.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vizokul.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call